Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 26;144(4):189–196. doi: 10.1016/j.jphs.2020.08.005

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 2 — Andrographolide sulfonate treatment prevented poly I:C-induced recruitment of inflammatory cells in lung tissue. Cells in BALF (bronchoalveolar lavage fluid) from each group were gathered and counted. Then they were stained with anti-CD3-APC, anti-CD11b-PE, anti-Gr1+-FITC and analyzed by FACS. Values were shown as the means ± SEM of 6 mice. ^∗P < 0.05, ^∗∗P < 0.01 vs. mice treated with poly I:C group. Andro-S: andrographolide sulfonate.